Oktay Özman

Dr. Oktay Özman


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2019 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
BABurak Arslan
Burak Arslan
SGSerkan Gönültaş
Serkan Gönültaş
EGErsin Gökmen
Ersin Gökmen
OÖOktay Özman
Oktay Özman
ÖOÖzkan Onuk
Özkan Onuk
EÖEnver Özdemir
Enver Özdemir

28 June 2019 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
BABurak Arslan
Burak Arslan
SGSerkan Gönültaş
Serkan Gönültaş
EGErsin Gökmen
Ersin Gökmen
OÖOktay Özman
Oktay Özman
MAMustafa Asım Avci
Mustafa Asım Avci
EÖEnver Özdemir
Enver Özdemir

28 August 2024 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
MŞMehmet Fatih Şahin
Mehmet Fatih Şahin
MAMurat Akgül
Murat Akgül
HÇHakan Çakır
Hakan Çakır
OÖOktay Özman
Oktay Özman
CBCem Başataç
Cem Başataç
BÖBülent Önal
Bülent Önal

20 February 2024 in Urology
Verified
Journal Article
Closed access
CYCenk Murat Yazici
Cenk Murat Yazici
KGKorcan Aysun Gönen
Korcan Aysun Gönen
OÖOktay Özman
Oktay Özman
HCHakan Cakir
Hakan Cakir
CBCem Basatac
Cem Basatac
HAHaluk Akpinar
Haluk Akpinar

3 April 2019 in Fetal and Pediatric Pathology
Verified
Journal Article
Closed access
ZAZeynep Aygün
Zeynep Aygün
ŞBŞebnem Batur
Şebnem Batur
ŞEŞenol Emre
Şenol Emre
TCTiraje Celkan
Tiraje Celkan
OÖOktay Özman
Oktay Özman
NCNil Comunoglu
Nil Comunoglu
Background: The aim of this study was to elucidate the significance of immunohistochemical staining patterns of ALK and GD2 in peripheral neuroblastic tumors with different stages and favorable/unfavorable features. Materials and methods: 32 neuroblastomas, 7 ganglioneuroblastomas, and 1 ganglioneuroma cases were immunohistochemically stained with ALK and GD2, and the expressions were graded and correlated with differentiation, size, and favorable/unfavorable histology. Results: There was no statistically significant correlation between ALK immunopositivity and tumor differentiation or stage. Although there was no statistically significant correlation between GD2 immunopositivity and stage, the intensity and prevalence of GD2 immunostaining were statistically significantly higher in the well differentiated group and in tumors which were smaller than 10 cm. Conclusion: GD2 immunostaining levels correlated with tumor differentiation and size. ALK immunostaining was not related to tumor differentiation or stage.

1 November 2022 in Journal of Urology
Verified
Journal Article
Open access
OÖOktay Özman
Oktay Özman
CTCorinne N. Tillier
Corinne N. Tillier
EMErik van Muilekom
Erik van Muilekom
LPLonneke V. van de Poll-Franse
Lonneke V. van de Poll-Franse
HPHenk G. van der Poel
Henk G. van der Poel
Purpose:The aim of the study was to evaluate frequency of financial toxicity among patients who underwent robot-assisted radical prostatectomy for prostate cancer.Materials and Methods:Data of 1,47...